Show simple item record

Files in this item


Item metadata

dc.contributor.authorRied, Thomas
dc.contributor.authorMeijer, Gerrit A.
dc.contributor.authorHarrison, David J.
dc.contributor.authorGrech, Godfrey
dc.contributor.authorFranch-Expósito, Sebastià
dc.contributor.authorBriffa, Romina
dc.contributor.authorCarvalho, Beatriz
dc.contributor.authorCamps, Jordi
dc.identifier.citationRied , T , Meijer , G A , Harrison , D J , Grech , G , Franch-Expósito , S , Briffa , R , Carvalho , B & Camps , J 2019 , ' The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome ' , Molecular Aspects of Medicine , vol. 69 , pp. 48-61 .
dc.identifier.otherPURE: 260441577
dc.identifier.otherPURE UUID: 9d1cd965-36bc-4907-90a2-2c6aa4c373b8
dc.identifier.otherRIS: urn:95FAEB024DC9BD10282B22E0B5B77DD9
dc.identifier.otherScopus: 85072153100
dc.identifier.otherORCID: /0000-0001-9041-9988/work/64034310
dc.identifier.otherWOS: 000486385900006
dc.descriptionThis work has been supported by the Instituto de Salud Carlos III and co-funded by the European Regional Development Fund (ERDF) [CP13/00160, PI14/00783, PI17/01304 to JC]; the Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya [2017 SGR 1035]; PERIS Generalitat de Catalunya [SLT002/16/00398 to JC]; Fundación Científica de la Asociación Española Contra el Cáncer [GCB13131592CAST]; the intramural program of the National Institutes of Health. CIBEREHD is funded by the Instituto de Salud Carlos III. This article is based upon work from COST Action [CA17118], supported by COST (European Cooperation in Science and Technology). RB is supported by a REACH HIGH Scholars Programme-PostDoctoral Grants. The grant is part-financed by the EU, Operational Programme II-Cohesion Policy 2014–2020 investing in human capital to create more opportunities and promote the wellbeing of society-European Social Fund.en
dc.description.abstractAneuploidy, the unbalanced state of the chromosome content, represents a hallmark of most solid tumors, including colorectal cancer. Such aneuploidies result in tumor specific genomic imbalances, which emerge in premalignant precursor lesions. Moreover, increasing levels of chromosomal instability have been observed in adenocarcinomas and are maintained in distant metastases. A number of studies have systematically integrated copy number alterations with gene expression changes in primary carcinomas, cell lines, and experimental models of aneuploidy. In fact, chromosomal aneuploidies target a number of genes conferring a selective advantage for the metabolism of the cancer cell. Copy number alterations not only have a positive correlation with expression changes of the majority of genes on the altered genomic segment, but also have effects on the transcriptional levels of genes genome-wide. Finally, copy number alterations have been associated with disease outcome; nevertheless, the translational applicability in clinical practice requires further studies. Here, we (i) review the spectrum of genetic alterations that lead to colorectal cancer, (ii) describe the most frequent copy number alterations at different stages of colorectal carcinogenesis, (iii) exemplify their positive correlation with gene expression levels, and (iv) discuss copy number alterations that are potentially involved in disease outcome of individual patients.
dc.relation.ispartofMolecular Aspects of Medicineen
dc.rightsCopyright © 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (
dc.subjectColorectal canceren
dc.subjectColorectal adenomasen
dc.subjectCopy number alterationsen
dc.subjectGene expressionen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectQH426 Geneticsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titleThe landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcomeen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Sir James Mackenzie Institute for Early Diagnosisen
dc.contributor.institutionUniversity of St Andrews. Cellular Medicine Divisionen
dc.description.statusPeer revieweden

This item appears in the following Collection(s)

Show simple item record